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Oocyte Meiotic Resumption under 
High Surveillance
François J. Richard
Abstract
Germinal vesicle breakdown (GVBD) is the hallmark of oocyte meiotic resump-
tion. It occurs under minimal stimulation during in vitro maturation (IVM). 
Several factors have been described to be involved in the inhibition of oocyte 
meiotic resumption such as purine derivatives. This study was assessing whether 
adenosinergic and guanosinergic systems are functional and participating in the 
inhibition of oocyte maturation. The objectives of the present study were to evalu-
ate the effect of two purines, adenosine (ADO) and guanosine (GUO), on in vitro 
oocyte meiotic resumption, cumulus cell expansion, and gap junction communica-
tion. Both ADO and GUO significantly inhibited GVBD oocytes. The inhibitory 
effect lasted 24 hours and was reversible for meiotic resumption and cumulus cell 
expansion. Both ADO and GUO increased gap junction communication in cumulus 
cells. Equine chorionic gonadotropin (eCG) and the adenylyl cyclase stimulator, 
forskolin (FK), were both supportive of ADO and GUO inhibitory effect. The 
results are suggesting both adenosinergic and guanosinergic systems efficient in 
inhibiting oocyte meiotic resumption. The use of these two systems as part of a pre-
IVM culture period would be a novel strategy to explore in order to improve oocyte 
developmental competence.
Keywords: oocyte, purine, adenosine, guanosine, meiotic resumption
1. Introduction
Oocyte meiosis begins during fetal development in large animals such as in cow, 
sow, and ewe. Once the sub-phases of the first prophase are completed, the oocyte 
meiosis stops at the dictyate stage. At this point, crossing over is a past event and 
chromatin is accessible for transcription. This G2/M phase transition of the cell 
cycle characterizes mammalian oocytes. The female gamete bears 4n chromosomes 
as long as the ovulatory LH peak generates its effect on the preovulatory follicle to 
induce oocyte meiotic resumption. Dysregulation of the oocyte cell cycle induced 
by c-MOS proto-oncogene after gene null mutation caused parthenogenic develop-
ment of the oocyte and explained female mouse infertility [1]. This phenotype 
illustrates how important it is to appropriately control oocyte meiotic resumption.
Oocyte meiotic resumption is a highly important physiological event for species 
survival since it refers to a successful reproduction by appropriately preparing the 
female gamete. This unique cell division has to occur at the right time and imply 
high surveillance. From an evolutionary point of view, the number of female 
gametes produced went from a large number, such as in frog, to a small number in 
mammals. Although several thousands of oocytes are found in the ovaries, only a 
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small percentage is ovulated, and even less are fertilized. Considering this selec-
tive restriction, a framework of the meiotic resumption process has developed. 
Throughout the evolutionary process, mechanisms have been added to ensure a very 
precise control of this crucial event related to species survival, which is the final 
phase of gamete preparation for fertilization. Interestingly, the role of EGF-like 
peptides fully fits with this notion. It is well-known that the LH peak induces oocyte 
meiotic resumption in the preovulatory follicles. However, the EGF-like peptides are 
also active participants in the ovulatory process, meiotic resumption, and cumulus 
cell expansion, clearly supporting an add-up to the LH surge. Going back to the 
control of oocyte meiotic resumption, although the contribution of cAMP and 
cGMP is well described, it is obvious that other mechanisms may still be involved 
and be discovered.
It has long been known that adenosine (ADO) is a molecule playing an impor-
tant role in various physiological systems such as in the central nervous system and 
cardiac function [2]. On the other hand, there are very few studies on the role of 
ADO in mammalian ovarian follicle. ADO is known to act on specific receptors, to 
cross plasma membrane using transporters, and to be generated from functional 
catabolism by extracellular enzymes, a system called adenosinergic [3]. On the 
other hand, guanosine (GUO) has not been as popular in research. However, in 
recent years a new interest on GUO has revealed its importance in the effect of ADO 
on the functioning of the central nervous system [4]. Although no specific receptor 
for GUO has been yet identified, its physiological impact leaves no doubt. GUO has 
neuroprotective effects, it diminishes the apoptotic effects observed in Parkinson’s 
disease, and it also has a protective role during a challenge with glutamate, during 
mitochondrial stress, and during ischemia [4–6]. Because GUO can also be gener-
ated by a functional catabolism using extracellular enzymes, these results support 
the existence of a so-called guanosinergic system.
ADO has also been identified in the follicular fluid with several other purine 
derivatives. Among these derivatives, hypoxanthine is the compound that has 
attracted the most studies in last three decades. In mice, ADO improves the inhibi-
tory effect of hypoxanthine on the resumption of meiosis but has no effect when 
used alone, even at a dose of 5 mM [7]. In the rat, the effect of ADO is also minimal 
[8]. In cattle, ADO used at 200 μM slowed meiotic resumption [9]. There is one 
study reporting that it has not been able to measure GUO in follicular fluid [10]. In 
contrast, GUO showed a very potent effect on the inhibition of meiotic resumption 
in mice [10] and rat [8].
This study is proposing to assess whether an adenosinergic and guanosinergic 
system are functional and participating in the inhibition of oocyte meiotic resump-
tion. Specifically, the research presented here aims to study the involvement of 
ADO and GUO in the physiology of the ovarian follicle by targeting their effect on 
in vitro meiotic resumption using swine as the animal model.
2. Material and methods
2.1 Chemicals
Unless otherwise stated, all chemicals were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). The adenylyl cyclase activator, forskolin (FK), was prepared 
as a millimolar stock solution and stored at −20°C as already described [11]. ADO 
and GUO were prepared from the stock powder directly in the culture medium on 
the day of the experiment. 8-Bromoadenosine (8-BrADO) and 8-Bromoguanosine 
(8-BrGUO) were dissolved in DMSO, and a DMSO control was run simultaneously. 
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The chemicals were added to the maturation medium a few hours prior to the addi-
tion of the oocytes.
2.2 Ovary collections
As previously described, prepubertal gilt ovaries were collected from a local 
slaughterhouse [12]. In brief, they were placed in saline (0.9% NaCl containing 
antibiotics and antimycotics, 100,000 IU/L penicillin G, 100 mg/L streptomycin, 
250 μg/L amphotericin B) and kept at 37°C. They were rinsed once in a fresh saline 
solution having antibiotics and antimycotics at 37°C.
2.3 Maturation medium
Oocytes were matured in BSA-free North Carolina State University 23 (NCSU) 
medium [13] supplemented with 25 μM β-mercaptoethanol (Bio-Rad, Hercules, 
CA, USA), 0.1 mg/mL cysteine, 10% (v/v) porcine follicular fluid (PFF), and 
gonadotropins (2.5 IU/well for hCG [APL, Ayerst Laboratories Inc., Philadelphia, 
PA, USA] and 2.5 IU/well for eCG [Folligon, Intervet, Whitby, ON, Canada]) 
[12]. PFF was collected from follicles of 2–6 mm in diameter. After centrifugation 
(1500×g, 30 minutes), the supernatant was filtered (0.8 and 0.45 μm) and stored at 
−20°C until used [11].
2.4 Recovery of cumulus-oocyte complexes (COC)
Cumulus-oocyte complexes were collected from follicles of 2–6 mm in 
diameter. They were aspirated with a 10-mL syringe and an 18G needle [11]. The 
follicular contents were pooled in 50-mL conical tubes (Falcon, Franklin Lakes, 
NJ, USA). The pellet was washed twice with HEPES-buffered Tyrode’s medium 
containing 0.01% (w/v) polyvinyl alcohol (PVA-TLH) [14]. The COC were 
recovered under a stereomicroscope and transferred to a petri dish containing 
PVA-TLH. The COC were washed three times with PVA-TLH and then subjected 
to their respective treatments. Groups of 20–30 COC were placed in the wells of 
four-well multi-dishes (Nunc, Roskilde, Denmark) containing 500 μL of matura-
tion medium. The COC were cultured at 38.5°C, 5% CO2 in 95% air atmosphere 
with 100% humidity.
2.5 Selecting COC and denuding oocytes
The criteria of selection were COC with a minimum of three layers of clear 
and compact cumulus cells which surrounded the oocyte [12]. Those with dark, 
pyknotic, or expanded cumulus cells, and those containing oocytes with a very 
clear cytoplasm or of small diameter were rejected. The oocytes were denuded of 
their cumulus cells by drawing several times the COC into a pipette using PVA-
TLH. Once denuded, the oocytes were rinsed in PVA-TLH, and those with a homo-
geneous cytoplasm were selected.
2.6 Assessment of oocyte nuclear maturation stage
The oocyte nuclear maturation stage was evaluated following a 48-hour fixa-
tion period in a solution of ethanol and acetic acid (3:1). Using a phase contrast 
microscope at 100 and 400× magnification immediately after staining with 1% 
aceto-orcein [15] allows us to assess oocyte nuclear maturation stage. Those having 
a nuclear membrane were considered at the germinal vesicle (GV) stage, whereas 
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those without a nuclear membrane were considered to have resumed meiosis. The 
oocytes were considered mature when they were in anaphase I, telophase I, and 
metaphase II.
2.7  Cumulus-cumulus gap-FRAP assay to measure gap junction 
communications (GJC)
After 4 hours of in vitro culture, COC were loaded with calcein-AM 
(39,69-di(O-acetyl)-29,79-bis(N,N-bis(carboxymethyl) amino methyl)-fluores-
cein) and tetra(acetoxymethyl ester) (Molecular Probes C-3100) in IVM medium 
containing 0.1 mg/mL PVA [16]. After 20 minutes at 38.5°C, the live COC were 
mounted on glass slides in the PVA-containing IVM medium. Fluorescence recovery 
after photobleaching (FRAP) assays were conducted using Nikon Eclipse TE2000-E 
inverted confocal microscope. The bleaching was performed for 5 minutes using 
laser pulses on a limited region of cumulus cells observed at a magnification of 90×. 
The COC were photographed at 60× before bleaching and every 3 minutes there-
after for 12 minutes. Fluorescence intensity was quantified using ImageJ software 
(National Institutes of Health, USA). A relative fluorescence value was achieved by 
dividing the raw fluorescence measurement in the bleached area by the mean fluo-
rescence in two adjacent regions. This value was further divided by the fluorescence 
value of a region at the opposite end of the COC to correct for unintended bleaching 
caused by the laser excitation.
2.8 Statistical analyses
All values are presented with their corresponding SEM, and the number of rep-
licates is indicated for each experiment (at least three). The data were analyzed by 
one-way ANOVA using GraphPad Prism v7.02 for Windows (GraphPad Software, San 
Diego, CA, USA). When ANOVA indicated a significant effect of treatment (P < 0.05), 
individual treatment differences were compared using Bonferroni’s multiple compari-
son post-hoc test. Significant effects were identified by * or different letters.
3. Results
In our hands, prior to in vitro maturation, more than 95% of swine oocytes have 
not started their nuclear maturation, that is, their meiotic resumption (<5% of 
GVDB oocytes), and cumulus cells have not expanded yet [12].
3.1 Adenosine inhibits oocyte meiotic resumption
The first experiment is aiming to assess ADO on inhibition of oocyte 
GVBD. When COC are cultured for 24 hours in control treatment, more than 
94.3 ± 3.0% of the oocytes were in GVBD, that is, oocyte meiotic resumption took 
place (Figure 1A). The inhibitory effect of ADO was dose-dependent with only 
13.9 ± 2.1% in GVBD after an exposure to ADO at 2.0 mM for 24 hours (Figure 1A). 
The EC50 of ADO on the percentage of GVBD oocyte is calculated as already 
described [11] and determined to be 1.3 mM. In addition, at 2.0 mM ADO inhibited 
cumulus cell expansion (Figure 1B5) compared with the control (Figure 1B1). When 
cultured for 24 hours as oocytes denuded of their cumulus cells (DO), ADO (2.0 mM) 
did not significantly inhibit oocyte GVBD compared with the control conditions 
(Figure 1C). These results support an inhibitory effect of ADO on both oocyte 
meiotic resumption and cumulus expansion when cultured as COC but not as DO.
5Oocyte Meiotic Resumption under High Surveillance
DOI: http://dx.doi.org/10.5772/intechopen.88291
3.2 Cell-permeable analog of adenosine (8-BrADO) inhibits GVBD
The following experiment is performed to assess a membrane-permeable 
analog of ADO, 8-BrADO (mimicking the intracellular effect). When COC are 
cultured for 24 hours, 12.2 ± 2.7% of the oocytes were in GVBD when treated 
with 2.0 mM ADO and 15.9 ± 0.8% when treated with 2.0 mM 8-BrADO 
(Figure 2A). These two treatments are significantly different to the control 
treatment (88.7 ± 2.9%; Figure 2A). The inhibition of cumulus cell expansion is 
also observed in both treatments (Figure 2B2 and B3). These results support that 
the inhibitory effect of ADO may be mimicked by the cell-permeable analog of 
adenosine, 8-BrADO.
3.3 Reversibility of GVBD inhibition
To assess the reversibility, the test compounds (ADO and 8-BrADO) are washed 
out, and the COC are cultured under control conditions for a second 24-hour 
Figure 1. 
Dose-response of ADO on both (A) the percentage of GVBD oocyte and (B) cumulus cell expansion. (C) Effect 
of ADO (2.0 mM) on the percentage of denuded oocytes in GVBD. Data are presented as the mean ± SEM of 
a minimum of three replicates. The number of oocytes used is illustrated in parentheses. Statistically significant 
effect of the treatment at P < 0.05 is shown by *. In (B) treatments were (1) Ct, (2) ADO 0.25 mM, (3) ADO 
0.5 mM, (4) ADO 1.0 mM, and (5) ADO 2.0 mM.
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period. The ADO-treated oocytes resumed meiosis showing no statistical differ-
ence with the control treatment, whereas a significant lower percentage of GVBD 
oocytes is observed following treatment with 8-BrADO (Figure 2C). Cumulus cell 
expansion is compromised by 8-BrADO (Figure 2D4), supporting an impairment 
of oocyte maturation (nuclear maturation and cumulus cell expansion) when 
using the halogenate compound. However, cumulus cells are expanding following 
reversibility treatment of the ADO-treated COC (Figure 2D2), supporting the 
reversibility of the ADO inhibitory effect. The appropriate controls are presented in 
Figure 2D1 and D3. These data are supportive of an adenosinergic system involved 
in the control of oocyte meiotic resumption.
Figure 2. 
Comparison of the effect of ADO (2.0 mM) with the cell-permeable analog 8-BrADO (2.0 mM) on both 
the percentage of GVBD oocytes and cumulus cell expansion after (A–B) 24 hours and (C–D) reversibility 
of 24 hours (Rev). DMSO treatment at 0.1% is the control for 8-BrADO. (C) Reversibility: COC were first 
cultured for 24 hours according to treatment and then cultured for a second 24 hours in control culture medium 
(Ct) to assess the reversibility of the inhibition of oocyte meiotic resumption. Data are expressed as the mean 
±SEM of a minimum of three replicates. The number of oocytes used is illustrated in parentheses. Statistically 
significant effect of treatment at P < 0.05 is shown by different letters and *. In (B), treatments were (1) Ct, (2) 
ADO, and (3) 8-BrADO. In (D) treatments were (1) Ct, (2) ADO, (3) DMSO, and (4) 8-BrADO.
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3.4  Gap junction communications measured by cumulus-cumulus gap-FRAP 
assay
Since gap junction communications are highly regulated during in vitro matura-
tion [17, 18], the aim of the following experiment was to measure the impact of 
Figure 3. 
Effect of ADO (A) on gap junction communication, (B) according to hormonal supplementation, and (C) according 
to FK supplementation. (A) The effect of ADO (2.0 mM) on gap junction communications in between cumulus 
cells measured by fluorescent recovery after photobleaching after 4 hours of in vitro culture. The COC were prepared 
using calcein-AM as fluorescent probe. The data were plotted as relative intensity and presented as the mean ±SEM 
of a minimum of three replicates. ADO-treated cumulus cells recover significantly more fluorescence than the control 
cumulus cells (P < 0.05). (B) The effect of ADO according to hormonal supplementation on the percentage of GVBD 
oocyte after 24 hours of in vitro maturation. ADO (2.0 mM) was added either with eCG or hCG or both eCG and 
hCG. Data are expressed as the mean ± SEM of a minimum of three replicates. Statistically significant effect of the 
treatment at P < 0.05 is shown by *. (C) The effect of ADO (2.0 mM) in the presence of either eCG and hCG or the 
adenylyl cyclase activator forskolin (FK, 1.1 μM), for 24 hours on the percentage of GVBD oocyte. Data are expressed 
as the mean ± SEM of a minimum of three replicates. The number of oocytes used is illustrated in parentheses. 
Statistically significant effect of the treatment at P < 0.05 is shown by *.
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ADO treatment on gap junction communications measured by cumulus-cumulus 
gap-FRAP assay using calcein-AM as already described [12, 16]. Gap junction com-
munication in cumulus cells was assessed after a 4-hour incubation in the presence 
of ADO (2.0 mM). The results show that gap junction communications between 
cumulus cells is increased following ADO treatment compared with the control 
treatment (Figure 3A). These results support that ADO maintains functional gap 
junctional communications between cumulus cells.
3.5 The contribution of eCG in adenosine treatment
The goal of the following experiment was to assess the contribution of 
gonadotropins in ADO-treated COC. The effect of ADO in inhibiting GVBD 
oocytes is observed in the presence of either eCG or hCG, or both in combination 
(Figure 3B). Comparison of ADO treatment supplemented with these hormones 
revealed no significant difference between eCG and the combination of eCG and 
hCG. However, a significant decrease in the percentage of GVBD was measured 
Figure 4. 
The effect of GUO (A) on the percentage of GVBD oocytes, (B) on cumulus cell expansion, (C) on 
reversibility, (D) on gap junction communication, and (E) according to FK supplementation. (A–B) 
Comparison of the effect of GUO (2.0 mM) and 8-BrGUO (2.0 mM) after 24 hours. (C) Reversibility: COC 
were first cultured for 24 hours in the presence of 2.0 mM of GUO and then cultured for a second 24 hours in 
control culture medium (Ct) to assess the reversibility of the inhibition of oocyte meiotic resumption. Data are 
expressed as the mean ± SEM of a minimum of three replicates. The number of oocytes used is illustrated in 
parentheses. Statistically significant effect of the treatment at P < 0.05 is shown by different letters. (D) The 
effect of GUO (2.0 mM) on gap junction communications in between cumulus cells measured by fluorescent 
recovery after photobleaching after 4 hours of in vitro culture. The data were plotted as relative intensity and 
presented as the mean ± SEM of a minimum of three replicates. GUO-treated cumulus cells recover significantly 
more fluorescence than the control cumulus cells (P < 0.05). (E) The effect of GUO (2.0 mM) in the presence of 
either eCG and hCG or the adenylyl cyclase activator forskolin (FK, 1.1 μM), for 24 hours on the percentage of 
GVBD oocyte. Data are expressed as the mean ± SEM of a minimum of three replicates. The number of oocytes 
used is illustrated in parentheses. Statistically significant effect of the treatment at P < 0.05 is shown by *. In 
(B), treatments were (1) Ct, (2) GUO, and (3) 8-BrGUO.
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between hCG alone and the combination of hCG and eCG (Figure 3B), showing 
the significant contribution of eCG to ADO-inhibiting GVBD, yet supporting an 
adenosinergic system.
3.6 Adenylyl cyclase activator (forskolin)
Since eCG contributes to ADO inhibitory effect, the following experiment was 
to evaluate the involvement of cAMP while using the adenylyl cyclase activator, 
forskolin. On itself, forskolin is significantly decreasing the percentage of GVBD 
oocytes (Figure 3C). ADO was significantly inhibiting GVBD both in presence 
of eCG-hCG and forskolin (Figure 3C). However, forskolin was not significantly 
Figure 5. 
The effect of supplementing both ADO and GUO (2.0 mM each) on (A) the percentage of oocyte meiotic 
resumption and (B) cumulus cell expansion. Data are expressed as the mean ± SEM of a minimum of three 
replicates. The number of oocytes used is illustrated in parentheses. Statistically significant effect of the treatment 
at P < 0.05 is shown by different letters. (B) The treatments were (1) Ct, (2) ADO 2.0 mM, (3) GUO 2.0 mM, 
(4) ADO 2.0 mM and GUO 2.0 mM.
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changing the percentage of GVBD compared with eCG-hCG (Figure 3C). The 
results are proposing the contribution of cAMP to ADO-inhibiting GVBD.
3.7 Guanosine inhibits oocyte meiotic resumption
High-performance liquid chromatography was used to detect the presence of 
GUO in porcine follicular fluid from follicles of 2–6 mm in diameter (data not 
shown). Since GUO was detected in PFF, we undertook to assess whether GUO 
could play a role in inhibiting GVBD. Figure 4 shows the significant effect of GUO 
in inhibiting both GVBD and cumulus expansion after 24 hours, highlighting the 
contribution of GUO in oocyte maturation. However, the membrane-permeable 
analog 8-BrGUO did not significantly inhibit GVBD (Figure 4A). Cumulus cell 
expansion was observed (Figure 4B3), supporting the inefficacy of 8-BrGUO in 
inhibiting oocyte GVBD and cumulus cell expansion. The reversibility treatment 
showed that GUO-treated COC resumed meiosis without any statistical significance 
compared with the control treatment (Figure 4C), supporting the reversibility of 
GUO inhibitory effect on GVBD. As ADO, GUO was also significantly increasing 
gap junction communication as measured by gap-FRAP assay (Figure 4D). Finally, 
forskolin was not significantly improving the inhibitory effect of GUO compared 
to eCG-hCG supplementation as measured on the percentage of GVBD oocytes 
(Figure 4E). GUO was also reversibly inhibiting oocyte GVBD, thus supporting a 
guanosinergic system.
3.8 The effect of using both ADO and GUO
The final experiment evaluated the effect of supplementing both ADO and 
GUO at 2.0 mM each on GVBD oocytes using COC (Figure 5A). The results showed 
that ADO, GUO, and both ADO and GUO were all significantly decreasing GVDB 
percentage compared with the control treatment. Although a significant effect of 
adding ADO with GUO was observed when compared with GUO (Figure 5A), the 
impact on the percentage went from 28.6 ± 1.4% for GUO to 11.8 ± 2.5% for ADO 
and GUO. Cumulus cell expansion was inhibited by ADO (Figure 5B2), GUO 
(Figure 5B3), and the combination of ADO and GUO (Figure 5B4) when com-
pared with the control (Figure 5B1).
4. Discussion
The present study showed that both ADO and GUO are efficient in revers-
ibly inhibiting swine oocyte GVBD (Figures 1 and 4). Cumulus cell expansion is 
significantly inhibited after 24 hours in presence to either ADO or GUO (Figures 1 
and 4), supporting that these two purine nucleosides inhibit oocyte maturation 
with low GVBD percentages and no cumulus cell expansion. Both ADO and GUO 
also increased GJC in cumulus cells (Figures 3 and 4). eCG and FK are both sup-
porting the two purines’ inhibitory effect (Figures 3 and 4). The data suggest that 
the inhibitory effect of these two purines on GVBD strengthens the involvement of 
both adenosinergic and guanosinergic systems in meiotic resumption.
Several years ago it was clearly shown that hypoxanthine, a purine derivative, was an 
important component of a low molecular weight fraction from porcine follicular fluid 
and efficient at inhibiting oocyte GVBD [19]. It was also reported that this fraction did 
not exclusively contain hypoxanthine [10]. Although hypoxanthine was efficient in the 
mouse and rat, the question was still not fully assessed regarding the efficacy of ADO 
and GUO on swine COC with respect to the inhibition of oocyte meiotic resumption.
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From a broader perspective, it is known that ADO is involved in several biologi-
cal functions such as nucleotide biosynthesis and cellular energy metabolism [19]. 
The cellular uptake of ADO played by two classes of nucleotide transporters (SLC28 
and SLC29) regulates these biological functions. Inside the cell, ADO is rapidly 
metabolized and either converted to inosine or adenosine monophosphate through 
adenosine deaminase or adenosine kinase, respectively [20]. Alternatively, extracel-
lular ADO may serve as a signaling molecule, which activates adenosine receptors 
(ADORA) on the cell membrane surface. Four different seven-transmembrane 
domain receptors have been described [21]. It has been reported that a low dose 
of ADO (0.2 mM) produced a transient delay in bovine oocyte GVBD [9]. After 
21 hours in culture, neither ADO nor hypoxanthine resulted in an efficient inhi-
bition of oocyte GVBD [9]. In the mouse, 4.0 mM of hypoxanthine was clearly 
efficient at inhibiting oocyte GVBD, while the use of ADO by itself did not produce 
a significant inhibition [10]. However, the efficacy was enhanced when ADO was 
used in combination with hypoxanthine [7]. This was also observed when ADO 
was used together with FSH [22], forskolin [23], or cAMP analogs such as 8-bromo-
cAMP [8]. Although these results have been provided to support that adenosine 
uptake and metabolism contribute to the inhibition of GVBD [24], ample evidence 
shows that functional adenosine receptors are present on ovarian cells [25]. The 
measured concentration of ADO in murine follicular fluid was between 0.38 
and 0.68 mM [7]. In the present study, the inhibitory effect on GVBD was dose-
dependent with an IC50 of 1.3 mM (Figure 1). Using 2.0 mM, ADO was efficient at 
reversibly inhibiting swine oocyte GVBD and cumulus cell expansion (Figure 1).
Although hypoxanthine and ADO have been measured in PFF [10], GUO has 
never been reported. In the present study, GUO has been found in PFF from 2 to 
6 mm diameter follicles (data not shown). While limited information is available 
in the literature regarding GUO, it has been described as having important func-
tions as an intercellular messenger especially in the central nervous system [4]. 
The mechanism underlying the neuroprotective properties of GUO is still not fully 
understood. One working hypothesis is that GUO may exert its biological effect 
by synchronizing distinct signaling pathways that may be related to the activa-
tion of purinergic receptor and specific G-protein binding sites [26–28]. In this 
study, 2.0 mM of GUO is reversibly inhibiting GVBD and cumulus cell expansion 
(Figure 5). In the mouse, GUO (1.0 mM) was reported to inhibit GVBD, while the 
same concentration of either hypoxanthine or ADO was inefficient [10]. In rats, the 
reported order of potency of these nucleosides was GUO > hypoxanthine > ADO 
[8]. In the mouse, there is an assumption based on a synergistic effect of ADO and 
GUO on the inhibition oocyte GVBD [7]. In the present study, the combination at 
2.0 mM significantly increased the effect of GUO (Figure 5). Thus, the inhibitory 
effect of the combination of both ADO and GUO are somewhat additive accord-
ing to the concentration used. Although GUO is proposed to activate a specific 
G-protein-coupled receptor with the involvement of P1 receptor [29], it has been 
recently reported that GUO functions as an extracellular signaling molecule 
without the need for GUO receptors [30]. In vascular smooth muscle cells, extracel-
lular GUO regulated extracellular ADO [30]. This proposed GUO-ADO mechanism 
further regulated cell proliferation in vitro [31] and decreased inflammation in vivo 
[32], supporting the additive inhibitory effect observed on oocyte GVBD.
We recently demonstrated the regulation of gap junction communications 
between cumulus cells during in vitro maturation [16–18]. An increase in gap 
junction communication was evident after 4 hours of in vitro culture [17, 18]. This 
observation provides an indication of how cumulus cells respond to the treatment 
and not only looking at cumulus cell expansion. In the present study, the effect of 
both treatments, ADO and GUO, was to increase gap junction communications 
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compared with the control (Figures 3 and 4). Since gap junction communica-
tions are known to play a primordial role in oocyte maturation [33, 34], this result 
supports a clear impact of the treatments on cumulus cell functions that may be 
beneficial for the oocyte.
This study also provides evidence of hormonal supplementation impacting the 
inhibition of GVBD oocytes by ADO (Figure 3). This ADO-mediated inhibition of 
GVBD oocytes is improved according to the supplementation. Although it is not the 
purpose of this study to understand how this effect is transduced into the cells, eCG 
clearly improved the effect of ADO in the presence of hCG. This FSH-type stimula-
tion seemed to be sufficient since the effect of eCG alone was not significantly 
different from that of eCG and hCG (Figure 3). As it is well-known that cumulus 
cells have an efficient response to FSH [35, 36], the inhibitory effect of ADO is 
significantly increased by FSH. This effect has been reported in the rat where the 
percentage of GVBD oocyte treated with ADO was decreased in the presence of 
FSH [22]. In addition, the FSH-induced granulosa cell differentiation was reduced 
by ADO [37], supporting the involvement of ADO in FSH response.
Although different forms of adenylyl cyclase have been characterized in oocytes and 
in cumulus cells [38], forskolin, a known adenylyl cyclase activator, makes a significant 
contribution to the inhibition of spontaneous maturation in several species as observed 
for rat [39], bovine [40], and porcine [11] oocytes. In the present study, forskolin inhib-
ited oocyte GVBD while treated with ADO (Figure 3C). Similar results were obtained 
in the presence of GUO (Figure 4E). These results support that constant stimulation 
of adenylyl cyclase, which increases the intracellular concentration of cAMP [40], pro-
moted the inhibitory effects of ADO and GUO. In this regard, the results are proposing 
the contribution of cAMP to both ADO- and GUO-inhibiting GVBD.
The effect of the two purines goes well with the current working model of inhi-
bition of oocyte GVBD involving C-type natriuretic peptide (CNP) as an oocyte-
meiosis-inhibiting peptide [41, 42]. CNP is involved in inhibiting oocyte GVBD 
[41, 43, 44]. CNP produced by granulosa cells is a ligand for NPR2, a member of 
guanylyl cyclase receptor family. NPR2 stimulation by CNP increased intracellular 
concentration of cGMP, inhibited oocyte phosphodiesterase type 3A, and thus 
maintained high intra-oocyte concentration of cAMP. The contribution of both 
purine nucleosides supports adenosinergic and guanosinergic system in the inhibi-
tion of oocyte meiotic resumption.
5. Conclusion
In conclusion, this study puts forward the contribution of ADO and GUO as 
inhibitory for oocyte GVBD in vitro suggesting that both adenosinergic and gua-
nosinergic systems are efficient in inhibiting oocyte meiotic resumption. The use of 
these two systems as part of a pre-IVM culture period would be a novel strategy to 
explore in order to improve oocyte developmental competence.
Finally, it should be emphasized that the signaling involved in oocyte meiotic 
resumption may be modulated through the contribution of different pathways. 
The adenosinergic and guanosinergic systems of which we have presented the 
contribution illustrate this situation for meiotic resumption. It is also to be expected 
that other studies will pave the way for additional contributions. For example, 
a preliminary study from our lab revealed that, as demonstrated in bovine [45], 
porcine theca cells secreted efficient factors involved in oocyte meiotic resumption. 
Without knowing these secreted elements, this result highlights that oocyte meiotic 
resumption is under the control of the ovarian follicular cells. Meiotic resumption is 
thus under high surveillance!
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